Prostate Carcinoma

Oncology·MeSH: Prostatic Neoplasms
51 drugs in development·10 companies·9 clinical trials

Drug Pipeline by Phase

Phase 3(24)
DrugCompany
Abiraterone AcetateARS Pharmaceuticals, Inc. (SPRY)
ApalutamideARS Pharmaceuticals, Inc. (SPRY)
ApalutamideMyovant Sciences Ltd. (MYOV)
Apalutamide 60 mg or 240 mg tabletsKYNTRA BIO INC. (KYNB)
CabazitaxelKYNTRA BIO INC. (KYNB)
degarelixKYNTRA BIO INC. (KYNB)
degarelixGH Research PLC (GHRS)
goserelinGH Research PLC (GHRS)
goserelinGH Research PLC (GHRS)
goserelinKYNTRA BIO INC. (KYNB)
Goserelin acetateKYNTRA BIO INC. (KYNB)
leuprolideGH Research PLC (GHRS)
leuprolideGH Research PLC (GHRS)
LeuprolideKYNTRA BIO INC. (KYNB)
Leuprolide acetateKYNTRA BIO INC. (KYNB)
New Formulation of Niraparib and Abiraterone AcetateARS Pharmaceuticals, Inc. (SPRY)
New Formulation of Niraparib and Abiraterone AcetateRoyalty Pharma plc (RPRX)
NiraparibARS Pharmaceuticals, Inc. (SPRY)
RelugolixMyovant Sciences Ltd. (MYOV)
Relugolix Combination TabletMyovant Sciences Ltd. (MYOV)
Rucaparib camsylateKYNTRA BIO INC. (KYNB)
triptorelinGH Research PLC (GHRS)
triptorelinGH Research PLC (GHRS)
VudalimabKYNTRA BIO INC. (KYNB)

Compare drugs

Abiraterone Acetate vs ApalutamideAbiraterone Acetate vs Apalutamide 60 mg or 240 mg tabletsAbiraterone Acetate vs Cabazitaxel

Frequently asked questions

How many drugs are in development for Prostate Carcinoma?

BioSniper tracks 51 drugs in development for Prostate Carcinoma across 10 companies.

How many clinical trials target Prostate Carcinoma?

There are 9 clinical trials targeting Prostate Carcinoma tracked by BioSniper.

Deep-dive into Prostate Carcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis